Skip to main navigation Skip to search Skip to main content

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial

  • A.ZygmuntAlexandarHOPE-3 Investigators

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry